Novel gene variants that modify the risk of late-onset Alzheimer's disease discovered

(Baylor College of Medicine) Researchers at Baylor College of Medicine and Texas Children's Hospital have identified 216 new genetic modifiers of late-onset Alzheimer's disease. The newly-identified biomarkers could potentially be used in the future to refine risk assessment, patient prognosis and act as therapeutic targets for this untreatable condition.